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Major advances in clinical and laboratory research methods have significantly clarified the identification and
natural course of rheumatic fever in
the past two decades. The advances in
methodology include the following:
Dia gnostic Purity of Population

The label of rheumatic fever is now
given to a population of patients more
distinct and diagnostically "pure" than
ever before. The Jones criteria, described in 1944 and modified in 1956
(American Heart Association, 1956),
circumscribe the diagnostic boundaries
of the disease, and exclude many minor
illnesses that formerly were designated
inappropriately as rheumatic fever.
Other major illnesses that once successfully masqueraded as rheumatic
fever, because they fulfilled the Jones
criteria, can now be unmasked and
properly identified by specific laboratory tests (such as those used for lupus
erythematosus, rheumatoid arthritis,
and sickle cell anemia) and by cardiac
catheterization (for congenital heart
disease). These diagnostic purifications
improve the homogeneity and reproducibility of a population of patients
with rheumatic fever, thus improving
the reliability of conclusions drawn
from observations of the population.
Spectrum of Post-strep tococcal In flammation

The frequent sequential testing of
multiple streptococcal antibodies (a
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laboratory technique developed mainly
in the past two decades) has demonstrated not only that acute rheumatic
fever is constantly associated with
Group A streptococcal infection, but
also that rheumatic fever is merely an
arbitrarily defined collection of events
in the complex clinical spectrum of inflammation which can follow streptococcal infection. Within this spectrum,
the main events used to identify rheumatic fever are arthritis, chorea, or
carditis-occurring alone, in various
combinations, or concomitantly with
other clinical features . Because so
many different combinations of events
can receive a diagnosis of rheumatic
fever, the clinical manifestations of the
disease demonstrate many apparently
disparate patterns. The differences in
these clinical patterns (Massell, Fyler,
and Roy, 1958; Feinstein and Spagnuolo, 1962) were responsible for
much of the past confusion in assessing etiology, pathogenesis, and prognosis. Some of the unclear issues recently resolved are noted below:

failure . When carditis occurs alone
without symptoms created by arthritis,
chorea, fever, or cardiac complications, the carditis will not be examined
while it is acute because the patient
will not seek medical attention; carditis can thus produce its valvular
scars silently. When the scars are discovered many years later, rheumatic
heart disease is said to have occurred
without a "history of rheumatic
fever." This type of rheumatic heart
disease is undetected clinically and develops insidiously only because the
patient is not examined during the
acute phase of the carditis. Had the
patient been symptomatic enough to
seek medical attention, the signs of
carditis could have been found. The
failure of clinicians to find such patients early is thus a fault neither
of clinicians nor patients; it is attributable to the natural behavior of the
disease. When post-streptococcal inflammation produces acute carditis
asymptomatically, it is clinically unexamined and hence undetected.

Isolated Chorea

Severity of Symptoms and Promptness
of Therapy

The latent interval after a streptococcal infection is usually much longer
for Sydenham's chorea than for other
"rheumatic" manifestations. Chorea
may therefore often appear as, or
after, other types of clinical rheumatic
inflammation subside. Or it may occur
alone, i.e., as "pure" chorea, long after
the streptococcal antibody titers have
receded to a level too low to permit
detection of the antecedent infection.

Asymptomatic Carditis
Carditis, another type of inflammation that can occur in the post-streptococcal spectrum, is ordinarily
asymptomatic if unaccompanied by
significant fever or by congestive heart

Although pathologists, from examination of tissue, have long known that
rheumatic fever "licks at the joints
and bites at the heart," the clinical
validity of this maxim, and of its converse has only recently been demonstrated (Feinstein and Spagnuolo,
1962). The patterns of clinical behavior in rheumatic fever show that
patients with severe arthritis are quite
commonly free of carditis, and those
with carditis severe enough to produce
congestive heart failure often have no
joint symptoms. This inverse relationship between the clinical severity of
arthritis and carditis is a feature of
natural history that creates a thera-
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peutic paradox in the disease. The
main reason that residual rheumatic
heart disease occurs less often in patients treated soon after onset of
symptoms than it does in those treated
late is that most patients who seek
treatment early usually do so because
of arthritis. They have little or no carditis to begin with. Conversely, the
late-treatment group consists predominantly of patients whose solitary carditis took a long time to produce
symptoms severe enough to make the
patients seek medical aid. In such patients, the cardiac damage when first
found is usually too great for cure by
anti-inflammatory therapy (Feinstein,
Stern, and Spagnuolo, 1964b). The
natural behavior of the illness, rather
than the treatment, is thus responsible
for many of the successes in which no
heart disease is found after early therapy.
Clinical Identification of Carditis

The assessment of the noises and
shadows used as evidence of carditis
has markedly improved in the past two
decades by recognition and removal of
several older diagnostic impediments:

Reliability of the Examiner
The reliability of the clinical examiner who observes and appraises the
audio-visual evidence of cardiac status
has been greatly improved by use of
objective, "blind," examining techniques, multiple examiners, precise descriptions, and rigorous criteria for interpretation. These improvements in
the scientific performance of the clinician have been aided, and sometimes
evoked, by modern methods of roentgenography and phonocardiography.
As a result of these clinical and technical improvements, better methods
and criteria (Feinstein et al., 1964a
and c) have evolved for avoiding two
types of observational error (described
in the next section) that formerly
created confusion in identifying the
status of patients, evaluating the results of therapy, and understanding the
pathogenesis of rheumatic valvular
disease.

Observational Errors and their Consequences
Errors can be expected during clini-

cal examination of the heart. Errors
of commission, in which physiologic
phenomena are mistakenly regarded
as pathologic, often arise in making
the diagnostic distinctions between:
physiologic systolic murmurs loudly
audible at the apex and those of mitral
regurgitation; long physiologic third
heart sounds and diastolic murmurs;
split first sounds and presystolic murmurs; artifactual curvature of the barium esophagram and left atrial enlargement; physiologic variations in
the roentgenographic cardiac silhouette and those due to cardiomegaly.
As a result of such errors of commission made during an acute rheumatic
attack, "carditis" initially would be diagnosed falsely and its "cure"-when
the true physiologic state was eventually recognized-would later be attributed inappropriately to therapy. At a
subsequent examination of a patient
previously (and correctly) deemed free
of carditis during the acute attack,
such errors would lead to the spurious
belief that rheumatic heart disease had
developed insidiously.
An error of omission occurs when
a pathologic phenomenon is undetected, or mistakenly regarded as
physiologic. Such errors commonly
arise from failure to recognize an
aortic diastolic or apical presystolic
murmur when it is present, particularly in situations where suspicion of
the murmur is not aroused by concomitant hemodynamic or roentgenographic abnormalities. If the abnormal
murmur persisted and eventually were
identified correctly, rheumatic heart
disease would be said to have developed insidiously in a patient believed
to be free of it.
The improved modern auscultatory
procedures described earlier have reduced the incidence of both types of
error, and accordingly, have reduced
the number of patients considered to
have developed rheumatic heart disease insidiously. Recent data (Feinstein et al., 1964a, b, and c; American
Heart Association, 1960) have shown
that insidious rheumatic heart disease
develops de novo primarily in patients
who were asymptomatic and unexamined while they had acute carditis,
and not in those examined during arthritis or chorea and found free of
valvular involvement.

Clarification of Ancillary Tests for
Carditis
Holding the belief that many noncarditic patients might later develop
insidious rheumatic heart disease,
clinicians had avidly searched for
diagnostic aids to find evidence of the
carditis that appeared to be clinically
undetectable. Chief among these aids
were the electrocardiogram and several laboratory tests. Although the
original search for these indices of undetectable "subclinical" carditis was
based on a premise that was itself not
valid, the lack of validity in the existing ECG and laboratory tests for carditis has been demonstrated independently. Prolongation of the P-R interval,
once regarded as a manifestation of
carditis, occurs in about one-third of
patients with post-streptococcal inflammation, regardless of concomitant
clinical evidence of acute carditis.
Moreover, in careful long-term studies (Feinstein et al., 1964a, b, and c;
American Heart Association, 1960),
acute P-R prolongation has been
shown to have no prognostic significance. Alteration of the QT, interval,
an observation whose value was never
proved initially, has now been abandoned as an index of acute rheumatic
carditis. Changes in electrocardiographic T waves of young patientsparticularly in III, in aVF, and in the
transitional precordial V leads-were
once regarded as evidence of carditis,
but are now interpreted with skepticism. Because of normal variations in
the anatomic position of the heart
during respiration and with different
phases of the cardiac cycle, and because of inconsistent placement of the
external probing electrode, T-waves
can vary greatly from one to another
of the repeated ECG's taken in children and adolescents during a rheumatic episode. Of the various laboratory tests popularized in the past 10
years, none-despite a transient, later
discredited, enthusiasm for transaminase-has convincingly been demonstrated to be a specific, reliable index
of carditis. Consequently, cardiac
noises and roentgenographic shadows
remain the major variables that indicate carditis clinically, and the physician remains the major apparatus for
assessing these variables.
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RHEUMATIC FEVER: NATURAL HISTORY AND TREATMENT
Clinical Course of Acute Rheumatic
Fever

For reasons already cited, no single
clinical pattern can . be properly representative of all the ways in which
rheumatic fever can appear and
evolve. The patterns are composed,
however, of individual clinical manifestations that often do have typical
courses. Untreated rheumatic arthritis
generally lasts no more than several
weeks, sometimes no more than a few
days, and leaves no residual defects.
The knees and ankles are affected most
commonly; elbows, wrists, and hips
are involved less often. Although small
joints of the hands and feet, and the
vertebral or temporo-mandibular joints
may be affected uncommonly in rheumatic fever, an alternate arthropathic
condition should always be considered
and ruled out when these joints are
involved. The arthritis of rheumatic
fever often can involve only one joint,
or several joints simultaneously. The
development of migratory and polyarticular arthritis, polyarticular arthritis alone, often depends upon the
severity of the attack, and the promptness with which bed rest or anti-inflammatory treatment is begun.
Like arthritis, Sydenham's chorea
also leaves no permanent defects, although the young patient may develop
many psychologic scars from scholastic deprivation and from anxieties that
the peculiar movements of the chorea
may induce in him or in the people
who deal with him. The duration and
severity of chorea vary unpredictably
in each patient, making an effective
evaluation of therapy difficult. Some
attacks last only a few weeks, while
others last three or four months. The
movements are rarely so severe as to
threaten the patient's safety, and often
they do not impair ambulation; most
commonly the patient is able to walk
but cannot write, dress, or feed himself. Erythema marginatum seldom
lasts more than one or two dayssometimes only a few hours-and, like
chorea, it often occurs late in a rheumatic attack. It can sometimes occur
early, however, but rarely alone. Subcutaneous nodules are seen much less
frequently today than in the past (the
reasons for the change are unknown)
and almost never occur alone without
some other rheumatic manifestation.
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The nodules most commonly are associated with carditis, and often with severe carditis.
If carditis occurs in a particular attack, the evidence is usually present
when the acutely ill patient is first encountered in the hospital (Massell et
al., 1958; Feinstein and Spagnuolo,
1962). After hospitalization, a patient
admitted with significant murmurs
may develop additional new murmurs,
rubs, changes in heart size, or congestive heart failure, but significant murmurs will seldom appear if none were
present during the first two weeks of
observation. In the most common situation, the patient's carditic manifestations are at their worst when he is
hospitalized, and they then persist or
subside during the ensuing acute
course of the illness.
The belief that acute rheumatic
fever was often a "polycyclic" illness
has also been revised in recent years.
If untreated, an episode of rheumatic
fever usually follows a course of
gradually declining inflammation, in
which laboratory abnormalities last
longer than clinical ones, except for
chorea. The sedimentation rate reaches
normal levels in an average of three
months for patients without carditis,
and in four months for those with carditis. Once a rheumatic attack has begun, anti-inflammatory treatment can
suppress some of the manifestations of
the inflammation, but the treatment
does not repair the damage done to
the heart. The attack may be followed
by rebounds that represent an outlet
for the inflammatory stimulus that remained dormant during the preceding
suppression of inflammation (Feinstein
and Spagnuolo, 1961). Post-therapeutic rebounds are one of three mechanisms by which acute rheumatic inflammation can recrudesce. A second
mechanism is a recurrence of acute
rheumatic fever, provoked by a new
streptococcal infection. A third mechanism, still poorly understood, is present in about 5% of patients with rheumatic fever. In these patients, the
acute attack is excessively prolonged
or "chronic," with clinical and laboratory evidence of acute inflammation
present for more than eight months in
the absence of an intervening streptococcal infection. Unlike post-therapeutic rebounds, the exacerbations of
inflammation in these "chronic" at-

tacks show no temporal relationship
to preceding suppressive treatment.
"Chronic" attacks are most likely to
occur in patients with severe cardiac
damage and in those who have had
many previous episodes of rheumatic
fever (Taranta, Spagnuolo, and Feinstein, 1962).
Long Term Sequelae of Rheumatic
Fever

Great improvements have been produced in the past two decades in epidemiologic methods for careful longterm observation of patient populations
having identified attacks of rheumatic
fever. Several recent large-scale studies
(Feinstein et al., 1964a, b, and c;
American Heart Association, 1960)
of rheumatic sequelae have been performed by cooperative efforts of different groups of investigators or by
single institutions, and have shown the
following results:
(a) Patients initially free of clinical
evidence of carditis remain essentially
free of it thereafter. Rheumatic heart
disease remains in about 9% of patients with equivocal initial evidence
of carditis.
(b) In patients with congestive heart
failure or marked cardiomegaly in the
acute attack, evidence of cardiac damage seldom disappears. Patients with
such severe carditis are the usual
source of those who die at an early
age. If they survive the acute rheumatic episode, the patients with severe
acute carditis often die later as a result of the remaining cardiac damage,
and not necessarily because of persistent or recurrent active rheumatic
inflammation.
(c) Significant murmurs later disappear in about 40% of patients who
had murmurs but no cardiomegaly or
decompensation during a rheumatic
attack. The disappearance of murmurs
is most likely to occur in patients with
systolic rather than diastolic murmurs,
with murmurs of one valve rather than
two, and with no previous episodes of
rheumatic fever.
(d) Except for a small percentage of
patients incapacitated by cardiac symptoms, most rheumatic patients have no
clinical impairment of cardiac function during adolescence, even though
signs of major cardiac damage may be
present. Restriction of scholastic or
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physical activities in such asymptomatic patients appears to have no
medical benefits and may create adverse psychosocial reactions (Feinstein et al., 1962).
(e) Recurrences of rheumatic fever
may make cardiac damage worse in
patients who already have it, but do
not generally bring valvular damage
to patients previously free of it. In
patients without previous valvular
damage, a recurrence is often manifested by arthritis, chorea, or occasionally pericarditis, but seldom by
persistent new valvular murmurs.
Treatment of Acute Rheumatic Fever

Although the many studies of therapy of acute rheumatic fever performed in the past decade have helped
clarify the course of the disease, they
have not reached uniform or consistent agreement about the value of
steroid treatment. The main difficulty
has been the absence of reproducibility in the different methods used to
allocate patients initially into comparable sub-groups of the rheumatic
spectrum, and to identify the presence
and disappearance of carditis (Feinstein, 1961). At present, steroids have
not been proved superior to salicylates
in the routine treatment of rheumatic
fever, nor has either of these agents
been proved consistently more effective than no treatment. Patients without carditis usually emerge free of
heart disease, and those with severe
carditis usually have residual heart
disease, regardless of the mode of
treatment. The comparison of therapeutic agents is thus best restricted to
patients with "mild" carditis, i.e., murmurs only. In such patients, current
therapeutic results are inconclusive
because of lack of uniformity in the
identification of murmurs by different
investigators.
Despite the many therapeutic controversies, certain approaches are accepted almost unanimously:
(a) A course of antimicrobial agents
adequate to eradicate streptococci
should be given when the diagnosis of
acute rheumatic fever is established,
even though throat culture and ASO
titer are normal. Massive doses of antibiotics for long periods of time have
not been proved more effective for
therapy of rheumatic fever than an

ordinary streptococcal-eradicating regimen.
(b) Patients without clinical evidence of carditis can be made comfortable by salicylates or analgesics,
and do not require steroids.
(c) Chorea is a yet unsolved therapeutic enigma, with no consistent success obtained by any of the various
sedatives, tranquillizers, and anti-inflammatory agents that have been
tested.
(d) Steroids are unequivocally better
than salicylates in a small percentage
of rheumatic patients who have overwhelming decompensated carditis, and
whose inflammation can not be controlled with salicylates. In these situations, the steroids do not seem to repair any of the damage left by the
rheumatic fire, but save the heart from
immediate acute destruction by the
fire, even though the severe residual
damage may lead to death a few years
later.
(e) In ordinary mild carditis, steroids have no unequivocally demonstrable superiority to salicylates. The
main advantage of steroids is a more
rapid clinical and laboratory disappearance of certain non-cardiac inflammatory abnormalities; the main
disadvantage of steroids is the frequent development of cutaneous striae
(in young patients) during treatment
and the common occurrence of rebounds after treatment. The rebound
phenomenon after steroids can often
be eliminated or minimized by giving
salicylates as overlap treatment, starting on the date of reduction in steroid
dosage and continuing for at least
several weeks after steroids are
stopped.
These clarifications in our knowledge of natural history of rheumatic
fever have come from better understanding of properties of the streptococcus and of the clinical reactions it
elicits in its human host. The next two
decades of research should help to
clarify the reasons and mechanisms
for susceptibility of the host.
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